- Home
- LEE vs RFL Comparison
LEE vs RFL Comparison
Compare LEE & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEE | RFL |
|---|---|---|
| Founded | 1890 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Real Estate |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.6M | 133.1M |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LEE | RFL |
|---|---|---|
| Price | $6.29 | $1.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.2K | ★ 130.8K |
| Earning Date | 11-25-2026 | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $543,955,000.00 | $917,000.00 |
| Revenue This Year | $4.44 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $3.34 | $1.12 |
| 52 Week High | $11.88 | $3.96 |
Technical Indicators
Market Signals| Indicator | LEE | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 33.22 |
| Support Level | $5.01 | $1.24 |
| Resistance Level | $8.79 | $1.38 |
| Average True Range (ATR) | 0.37 | 0.10 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 18.98 | 20.00 |
Price Performance
Historical ComparisonAbout LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.